NR4A1 and breast carcinoma: Immunohistochemical studies in tissue microarrays have confirmed the results of cDNA expression profiling and have identified identical breast carcinoma phenotypes; that is, two hormonal receptor-positive groups with luminal epithelial differentiation, a group with dominant HER2/neu expression, and a group with basal epithelial characteristics [9].